Zacks Investment Research Lowers DLH (NASDAQ:DLHC) to Hold

DLH (NASDAQ:DLHC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Thursday, Zacks.com reports.

According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “

Separately, Noble Financial reaffirmed a “buy” rating and issued a $14.00 target price on shares of DLH in a report on Friday, September 24th.

Shares of DLHC stock traded up $0.06 on Thursday, reaching $13.45. The stock had a trading volume of 27,886 shares, compared to its average volume of 24,958. The stock has a market cap of $168.73 million, a P/E ratio of 21.35 and a beta of 1.05. DLH has a 1 year low of $9.00 and a 1 year high of $16.79. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.91 and a current ratio of 0.91. The company has a 50 day simple moving average of $13.69 and a 200 day simple moving average of $12.09.

A number of large investors have recently bought and sold shares of the business. Morgan Stanley grew its position in shares of DLH by 43.4% during the third quarter. Morgan Stanley now owns 4,064 shares of the business services provider’s stock valued at $50,000 after purchasing an additional 1,230 shares in the last quarter. Marshall Wace LLP purchased a new position in shares of DLH during the first quarter valued at about $59,000. O Shaughnessy Asset Management LLC grew its position in shares of DLH by 88.5% during the third quarter. O Shaughnessy Asset Management LLC now owns 6,656 shares of the business services provider’s stock valued at $82,000 after purchasing an additional 3,125 shares in the last quarter. Citadel Advisors LLC grew its position in shares of DLH by 25.2% during the first quarter. Citadel Advisors LLC now owns 15,191 shares of the business services provider’s stock valued at $151,000 after purchasing an additional 3,056 shares in the last quarter. Finally, Raymond James & Associates purchased a new position in shares of DLH during the third quarter valued at about $157,000. 64.08% of the stock is currently owned by institutional investors and hedge funds.

DLH Company Profile

DLH Holdings Corp. engages in the provision of technology enabled business process outsourcing program management solutions and public health research and analytics. It mainly focuses to improve and better deploy large-scale federal health and human service initiatives. The company was founded in 1969 and is headquartered in Atlanta, GA.

See Also: S&P/TSX Index

Get a free copy of the Zacks research report on DLH (DLHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with MarketBeat.com's FREE daily email newsletter.